Results 31 to 40 of about 26,501 (228)
Preresection transarterial chemoembolization for hepatocellular carcinoma [PDF]
Indian Journal of Gastroenterology, 2015 Sir, The recent report on “preresect ion transarter ial chemoembolization for hepatocellular carcinoma” is very interesting [1]. Goel et al. concluded that “encouraging outcomes in terms of disease recurrence and overall survival need to be balanced with the risk of surgical dropout and perioperative complications when selecting patients for ...
Sim Sai, Tin, Viroj, Wiwanitkit
openaire +2 more sources
Anti-angiogenesis in hepatocellular carcinoma treatment : current evidence and future perspectives [PDF]
, 2011 Hepatocellular carcinoma (HCC) is among the most common cancer diseases worldwide. Arterial hypervascularisation is an essential step for HCC tumorigenesis and can be targeted by transarterial chemoembolization (TACE).
Trojan, Jörg, Welker, Martin-Walter
core +1 more source
Radiology Case Reports, 2018 The mainstay of treatment for unresectable hepatocellular carcinoma is locoregional therapy including percutaneous ablation and transarterial chemo- and radioembolization.
Sriharsha Gummadi, MD +5 more
doaj +1 more source
Role of transarterial chemoembolization as neoadjuvant treatment in T2 stage patients waiting for liver transplantation [PDF]
, 2012 RIASSUNTO Scopo: Valutare retrospettivamente i risultati clinici a lungo termine di pazienti cirrotici con HCC allo stadio T2 sottoposti a trapianto ortotopico di fegato (TOF) dopo chemioembolizzazione intraarteriosa (TACE), rispetto ai risultati ...
BARATTINI, MATTEO
core +1 more source
Journal of Veterinary Internal Medicine, 2021 Background Effective treatment options for nonresectable hepatic carcinoma (HC) in dogs are limited. Hypothesis/Objective Objectives were to report outcomes, complications, and tumor responses via computed tomography (CT) assessment after drug‐eluting ...
Cleo P. Rogatko +4 more
doaj +1 more source
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma [PDF]
BMC Cancer, 2015 To compare the overall survival of patients with hepatocellular carcinoma (HCC) who were treated with lipiodol-based conventional transarterial chemoembolization (cTACE) with that of patients treated with drug-eluting bead transarterial chemoembolization (DEB-TACE).By an electronic search of our radiology information system, we identified 674 patients ...
Klöckner, Roman +6 more
openaire +3 more sources
Case Reports in Hepatology, 2013 Introduction. Transarterial chemoembolization is the first-line treatment in unresectable hepatocellular carcinoma. There is no standard treatment after transarterial chemoembolization failure. We report the case of a patient with advanced hepatocellular
Francesco Fiorica +6 more
doaj +1 more source
Acta Médica Portuguesa, 2018 Introduction: Hepatic transarterial chemoembolization is a widely used technique for the treatment of hepatocellular carcinoma. The most common complication of this procedure is postembolization syndrome.
Mariana Lima +4 more
doaj +1 more source
Transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma: response analysis with mRECIST [PDF]
, 2021 PURPOSEAccording to the Barcelona Clinic Liver Cancer (BCLC) staging classification, transarterial chemoembolization (TACE) is the treatment of choice for intermediate hepatocellular carcinoma (HCC).
Christina Malessa +3 more
core +1 more source
Future Science OA, 2021 Aim: A meta-analysis was conducted to evaluate the clinical significance of serum thymidine kinase 1 protein concentration (STK1p) in distinguishing between hepatocellular carcinomas (HCC) and non-HCC for predicting early progression and monitoring the ...
Hongbo Ma +5 more
doaj +1 more source